SANDOSTATIN – octreotide acetate 50 mcg/mL, 100 mcg/mL, and 500 mcg/mL injection solution

Novartis Pharmaceuticals Corp

irritable bowel syndrome; irritable bowel syndrome; chemotherapy-induced diarrhea; carcinoid syndrome; chemotherapy-induced diarrhea; bleeding esophageal varices; acromegaly; dumping syndrome; diarrhea from HIV; dumping syndrome; carcinoid crisis; bleeding esophageal varices; short bowel syndrome; diarrhea associated with VIP-secreting tumor; carcinoid syndrome; nesidioblastosis; insulinoma; short bowel syndrome; insulinoma; diarrhea associated with VIP-secreting tumor; acromegaly; diarrhea from HIV; nesidioblastosis; carcinoid crisis

diarrhea from HIV; short bowel syndrome; nesidioblastosis; chemotherapy-induced diarrhea; bleeding esophageal varices; insulinoma; irritable bowel syndrome; carcinoid syndrome; carcinoid crisis; irritable bowel syndrome; diarrhea associated with VIP-secreting tumor; acromegaly; diarrhea associated with VIP-secreting tumor; bleeding esophageal varices; insulinoma; carcinoid crisis; dumping syndrome; carcinoid syndrome; acromegaly; nesidioblastosis; dumping syndrome; chemotherapy-induced diarrhea; short bowel syndrome; diarrhea from HIV

diarrhea associated with VIP-secreting tumor; insulinoma; short bowel syndrome; acromegaly; carcinoid crisis; irritable bowel syndrome; nesidioblastosis; carcinoid syndrome; diarrhea from HIV; bleeding esophageal varices; chemotherapy-induced diarrhea; dumping syndrome

Ampul: Controlled Room Temp (20-25°C)

Solution: Fridge (2-8°C)